Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk

NCT02357368 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

HIV
Contraception

Interventions

DRUG: Depot medroxyprogesterone acetate (DMPA)
DEVICE: Etonogestrel implant (Eng-Implant)
DEVICE: Levonorgestrel intrauterine device (Lng-IUD)
DEVICE: ParaGard® T 380A Intrauterine Copper Contraceptive

Sponsor

Lisa Haddad

Collaborators

[object Object]